Menu
CooperCompanies ("Cooper") is a global medical device company. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 12,000 with products sold in over 100 countries.
6101 Bollinger Canyon Rd Ste 500
San Ramon, California 94583
Phone: 19254603600
www.coopercos.com
Sumitomo Life Insurance Co. decreased its stake in shares of The Cooper Companies, Inc. (NYSE:COO – Free Report) by 8.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,371 shares of the medical device company’s stock after selling 318 shares […]
Hutchens & Kramer Investment Management Group LLC reduced its holdings in shares of The Cooper Companies, Inc. (NYSE:COO – Free Report) by 13.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,528 shares of the medical device company’s stock […]
This analysis questions Cooper Companies'' ability to grow earnings at attractive rates on capital deployed. Find out why I downgrade COO stock from buy to hold.
Cooper Companies'' Q3 earnings beat expectations, but GAAP earnings decreased by 14% YoY. Learn why COO shares have now delivered intermediate sell signal.
Despite revenue growth, higher costs and expenses have put pressure on The Cooper Companies'' bottom line. Learn why COO shares have dropped since earlier this year.
The Cooper Companies, Inc. has above average growth and margin leverage potential. Click here to find out why COO stock is rated as a buy.
Wednesday, Cooper Companies (NYSE: COO ) reported Q3 adjusted EPS of $3.35, slightly ahead of the consensus Of $3.34 . The company reported Q3 sales of $930.20 million, up 10% Y/Y, up 11% in constant currency, up 12% organically, beating the consensus of $899.75 million . The company sees FY24 adjusted EPS of $12.72-$12.90 compared to the consensus of $12.82 . It sees revenue of $3.578-$3.595 billion versus the consensus of $3.55 billion. After yet another robust quarter in revenue, William … Full story available on Benzinga.com
Unveiling the Investment Potential of The Cooper Companies Inc (COO): A Comprehensive Analysis of Financial Metrics and Competitive Strengths
